Grown Rogue International (GRUSF) Shares Outstanding (Diluted Average) (2010 - 2025)

Grown Rogue International (GRUSF) recorded quarterly Shares Outstanding (Diluted Average) of $255.6 million in Q3 2025, little changed quarter-over-quarter from $256.5 million in Q2 2025, and up 39.53% on a YoY basis from $183.1 million in Q3 2024.

Grown Rogue International (GRUSF) Shares Outstanding (Diluted Average) (2010 - 2025) Analysis & Trends

Grown Rogue International's Shares Outstanding (Diluted Average) history runs 12 years deep, the most recent figure standing at $255.6 million for Q3 2025.

  • In Q3 2025, Shares Outstanding (Diluted Average) rose 39.53% year-over-year to $255.6 million; the TTM figure through Sep 2025 stood at $255.6 million (up 39.53% YoY), while the FY2024 annual figure was $237.4 million, up 10.92% from the prior year.
  • Shares Outstanding (Diluted Average) was $255.6 million for Q3 2025 at Grown Rogue International, roughly flat from $256.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $256.5 million in Q2 2025 to a low of $135.2 million in Q4 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $203.5 million across 5 years, with a median of $198.6 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) increased 5.46% in 2023, then jumped 43.95% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $135.2 million in 2021, then rose by 25.11% to $169.2 million in 2022, then climbed by 26.51% to $214.0 million in 2023, then advanced by 10.92% to $237.4 million in 2024, then increased by 7.63% to $255.6 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $255.6 million (Q3 2025), $256.5 million (Q2 2025), and $249.2 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.18 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Grown Rogue International - - 3.96 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 255.55 Mn
Jun 30, 2025 256.53 Mn
Mar 31, 2025 249.24 Mn
Dec 31, 2024 237.43 Mn
Sep 30, 2024 183.15 Mn
Jun 30, 2024 178.21 Mn
Mar 31, 2024 214.05 Mn
Dec 31, 2023 214.05 Mn
Oct 31, 2023 178.43 Mn
Jul 31, 2023 170.83 Mn
Oct 31, 2022 169.19 Mn
Oct 31, 2021 135.23 Mn
Aug 31, 2017 2.07 Bn
May 31, 2017 2.67 Bn
Feb 28, 2017 27.19 Bn
Nov 30, 2016 27.18 Bn
Aug 31, 2016 1.60 Bn
May 31, 2016 16.91
Feb 29, 2016 14.41
Nov 30, 2015 1,444.76